Home » CyDex Presents Trial Results for Combination Solution Nasal Spray
CyDex Presents Trial Results for Combination Solution Nasal Spray
CyDex Pharmaceuticals, Inc. announced the presentation of Phase 2 clinical trial results of its novel, proprietary Captisol-Enabled budesonide/azelastine nasal spray (CDX-313) for seasonal allergic rhinitis (SAR).
TradingMarkets
TradingMarkets
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May